ID
31324
Description
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism
Mots-clés
Versions (1)
- 13/08/2018 13/08/2018 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
13 août 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Clinical Study ID: AR1104574
Adverse Event Report
- StudyEvent: ODM
Description
Adverse event
Alias
- UMLS CUI-1
- C0877248
Description
Adverse event
Type de données
text
Alias
- UMLS CUI [1]
- C0877248
Description
Adverse event; Date of onset
Type de données
date
Alias
- UMLS CUI [1]
- C2985916
Description
Adverse event; start time
Type de données
time
Alias
- UMLS CUI [1]
- C2697889
Description
Adverse event; maximum intensity
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0518690
Description
Adverse event; Relationship; study drug
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
Description
Adverse event; Relationship; study drug; action taken
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C2826626
Description
Adverse event; Relationship; study drug; corrective therapies
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C0087111
- UMLS CUI [1,5]
- C0719519
Description
Adverse event; Outcome
Type de données
text
Alias
- UMLS CUI [1]
- C1705586
Description
Adverse event; seriousness criteria
Type de données
boolean
Alias
- UMLS CUI [1]
- C1710056
Description
Adverse event; seriousness; date
Type de données
date
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C0808070
Description
Adverse event; seriousness; time
Type de données
time
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C1301880
Description
Adverse event; seriousness criteria
Type de données
text
Alias
- UMLS CUI [1]
- C1710056
Description
Adverse event; significan bleeding
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0019080
Similar models
Adverse Event Report
- StudyEvent: ODM
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
C2348585 (UMLS CUI [1,2])
C0518690 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C2826626 (UMLS CUI [1,4])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0719519 (UMLS CUI [1,5])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0019080 (UMLS CUI [1,2])